Christopher Dinsmore, Chief Scientific Officer at Kronos Bio, Inc. (KRON), bought 5,250 shares at $19.00 ($100K) on 2020-10-14, disclosed to the SEC on 2020-10-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| KRON | SELL | 2023-07-07 | $12K | — | Filing → |
| KRON | SELL | 2023-02-24 | $11K | — | Filing → |
| KRON | SELL | 2022-12-14 | $17K | — | Filing → |